U.S. Next-generation Sequencing Data Analysis Market Size & Outlook

The next-generation sequencing data analysis market in the United States is expected to reach a projected revenue of US$ 2,194.5 million by 2030. A compound annual growth rate of 23.9% is expected of the United States next-generation sequencing data analysis market from 2024 to 2030.
Revenue, 2023 (US$M)
$489.3
Forecast, 2030 (US$M)
$2,194.5
CAGR, 2024 - 2030
23.9%
Report Coverage
U.S.

U.S. next-generation sequencing data analysis market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. next-generation sequencing data analysis market highlights

  • The U.S. next-generation sequencing data analysis market generated a revenue of USD 489.3 million in 2023 and is expected to reach USD 2,194.5 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 23.9% from 2024 to 2030.
  • In terms of segment, services was the largest revenue generating product in 2023.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


Next-generation sequencing data analysis market data book summary

Market revenue in 2023USD 489.3 million
Market revenue in 2030USD 2,194.5 million
Growth rate23.9% (CAGR from 2023 to 2030)
Largest segmentServices
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationServices, NGS Commercial Software
Key market players worldwideBio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen


Other key industry trends

  • In terms of revenue, U.S. accounted for 45.4% of the global next-generation sequencing data analysis market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. next-generation sequencing data analysis market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 2,194.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Next-generation Sequencing Data Analysis Market Scope

Next-generation sequencing data analysis market segmentation & scope
Services
Platform OS/UI
Protein Seq Alignment
DNA Seq Alignment
RNA Seq Alignment
QC/Pre-processing Tools
Others
NGS Primary Data Analysis
Variant Alignment & Variant Calling
Read Mapping
Targeted sequencing/Gene Panel
RNA seq
Exome
Whole Genome
ChIp Seq
Other
Variant Annotation
In-house Data Analysis
Outsourced Data Analysis
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other users
Short Read Sequencing
Long Read Sequencing
Very Long Read Sequencing

Next-generation Sequencing Data Analysis Market Companies

Name Profile # Employees HQ Website

U.S. next-generation sequencing data analysis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.


Services was the largest segment with a revenue share of 53.98% in 2023. Horizon Databook has segmented the U.S. next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. is witnessing rapid developments in NGS data analysis methodologies for applications in oncology and infectious diseases, which is expected to boost the market in the country. Furthermore, the large revenue share of the U.S. can also be attributed to the presence of market leaders, such as Illumina, Roche, Thermo Fisher, and Agilent Technologies, which are involved in various strategic initiatives to boost their market share.

For instance, in June 2020, Illumina acquired a cloud-based software company, Blue Bee, which offers genomics analysis solutions for clinical & research applications. This acquisition integrated the capabilities of Blue Bee into cloud portfolio of Illumina to provide flexibility to its customers during data processing.

Moreover, in February 2021, QIAGEN announced strategic partnerships with five different companies with an aim to consolidate its digital genome knowledge base. The new partnerships are aimed at delivering Al-based NGS data analysis services for oncology.

Reasons to subscribe to U.S. next-generation sequencing data analysis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. next-generation sequencing data analysis market databook

  • Our clientele includes a mix of next-generation sequencing data analysis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. next-generation sequencing data analysis market size, by product, 2018-2030 (US$M)

U.S. Next-generation Sequencing Data Analysis Market Outlook Share, 2023 & 2030 (US$M)

U.S. next-generation sequencing data analysis market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more